High Mark Wealth Management LLC Gilead Sciences, Inc. Transaction History
High Mark Wealth Management LLC
- $182 Million
- Q3 2024
A detailed history of High Mark Wealth Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, High Mark Wealth Management LLC holds 118 shares of GILD stock, worth $10,309. This represents 0.0% of its overall portfolio holdings.
Number of Shares
118
Previous 117
0.85%
Holding current value
$10,309
Previous $8,000
12.5%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding GILD
# of Institutions
1,890Shares Held
1.02BCall Options Held
12MPut Options Held
8.96M-
Black Rock Inc. New York, NY121MShares$10.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.1 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$6.66 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$5.28 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$5.18 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $110B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...